Ureteral Stents

Ucuzal, Meral; Serçe, Perihan

doi:10.1097/hnp.0000000000000200

Cited by 14 publications

(12 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Postoperative stenting has become the most frequent cause of morbidity in ureteroscopic stone removal. Joshi et al [ 24 ] and Ucuzal et al [ 25 ] reported that patients with stents had undesirable consequences and a significantly negative impact on patients’ quality of life. Therefore, whether it is necessary to routinely insert a stent after ureteroscopy for ureteric calculi remains controversial.…”

Section: Discussionmentioning

confidence: 99%

Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial

Demour

Alrabadi

AlSharif

et al. 2020

Arab Journal of Urology

View full text Add to dashboard Cite

Objective: To compare three groups of patients who underwent uncomplicated ureteroscopic lithotripsy (URSL) and to evaluate whether stenting could be eliminated after the procedure, as there is no consensus about whether a ureteric stent should be placed after uncomplicated ureteroscopy for stone retrieval. Patients and methods: In this randomised clinical trial (NCT04145063) 105 patients underwent uncomplicated URSL for ureteric stones. They were prospectively randomised into three groups: Group 1 (34 patients) with a double pigtail ureteric stent, Group 2 (35 patients) with a double pigtail ureteric stent with extraction string, and Group 3 (36 patients) with no ureteric stent placed after the procedure. The outcomes measured were: postoperative visual analogue scale (VAS) score for flank pain and dysuria score, urgency, frequency, suprapubic pain, haematuria, analgesia requirement, operative time, re-hospitalisation, and return to normal physical activity. Results: The mean (SD) operative time was significantly longer in groups 1 and 2 compared to Group 3, at 22.2 (9.1), 20.2 (6) and 15.1 (7.1) min, respectively (P < 0.001). The results of the VAS for flank pain and dysuria scores, urgency, frequency, haematuria, and suprapubic pain showed a significant difference at all time-points of follow-up, being significantly higher in groups 1 and 2 compared to Group 3 (all P < 0.001). Further analysis showed that measured outcomes, and analgesia need for groups 1 and 2 were similar, at all time-points except at week 1 and 1 month where Group 2 patients' had less symptoms (P < 0.001). Conclusion: Double pigtail ureteric stent placement appears to be unnecessary in procedures considered 'uncomplicated' by operating urologists during surgery. The advantages of the double pigtail ureteric stent with extraction string over the double pigtail ureteric stent only include earlier and easier removal with earlier relief of symptoms, and less analgesia requirements.

show abstract

Section: Discussionmentioning

confidence: 99%

Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial

Demour

Alrabadi

AlSharif

et al. 2020

Arab Journal of Urology

View full text Add to dashboard Cite

show abstract

“…7 In the literature, double-J ureteral catheterisation patients have reported complaints such as hematuria, frequent urination, dysuria, pain, migration, encrustation, detachment, urinary infection, insomnia and anxiety. 3,6,[8][9][10] A significant portion of double-J catheterised patients say that they experience pain, and that their job performance is affected. 9,11 In recent years, it has been emphasised that minor urological interventions can also harm sexual function.…”

Section: Discussionmentioning

confidence: 99%

“…7 Previous studies have found that lower urinary tract symptoms emerge after catheter replacement, which causes psychological problems, such as anxiety and depression. 3,6,[8][9][10]18 These symptoms negatively affect patients' life quality 8,10,26 and sexual function. 14 The patients had a mild ED before placement, and they had moderate ED a month after the procedure (Table 3).…”

Section: Discussionmentioning

confidence: 99%

Sexual dysfunction in patients after double‐J catheterisation: A cross‐sectional, prospective study

Özlü

Kılınç

et al. 2021

Int J Clin Pract

View full text Add to dashboard Cite

Ureteral catheterisation is a practice that has been frequently used in urology since 1967.It is used before surgical interventions, to monitor urinary output, in cases of urinary incontinence and to remove urinary obstructions. 1,2 Double-J ureteral catheterisation is commonly used as an effective treatment for ureteral obstructions. It is called a double-J catheter because its two ends look like the letter J with curving ends that prevent the stent slipping into the bladder or the kidney. The indwelling time of double-J catheter is directly related to the reason for catheterisation. The catheter is usually placed for 2-4 weeks after a kidney stone operation and frequently placed for 6 weeks after laparoscopic or open urethral stricture surgery. 3 Double-J catheters are used to maintain urinary flow from the kidney to the bladder in intrinsic or extrinsic pathologies causing ureteral obstruction or

show abstract

“…Along with percutaneous nephrostomy, ureteral stenting is the main wide-using method for successful elimination of the upper urinary tract obstruction different etiology [ 1 , 2 ]. Long-term inserted ureteral stent as a foreign body inside of urinary tract is causing the symptoms of irritation that usually make a negative influence on quality of life in a patient [ 3 ]. Ureteral stents-related symptoms (USRs) are the common complications of ureteral stent indwelling and may occur in 80% patients or even more [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

Efficacy of combination therapy Tadalafil plus Tamsulosin in ureteral stents-related symptoms relief

2023

Cent European J Urol

View full text Add to dashboard Cite

Introduction Ureteral stents-related symptoms (USRs) are the common complications of ureteral stenting. Tamsulosin a selective alpha-1 blocker and Tadalafil a PDE-5 inhibitor are one of drugs have been used for USRs relief. In this study we aimed to evaluate the effectiveness and safety of combination therapy Tamsulosin+Tadalafil for treating USRs comparing it with the efficacy of either Tamsulosin or Tadalafil monotherapies. Material and methods 279 patients with indwelled unilateral ureteral stents were randomized to Tamsulosin 0.4 mg + Tadalafil 5 mg once a day (Group 1, n = 67), Tamsulosin 0.4 mg once a day (Group 2, n = 71), Tadalafil 5 mg once a day (Group 3, n = 69) and Placebo once a day (Group 4, n = 72). USRs severity was registered and calculated by using the Ureteral Symptoms Score Questionnaire (USSQ) at the 14 th day of treatment. Side-effects and total analgesic use were recorded and compared. Results At the endpoint in patients with unilateral ureteral stents the combination therapy Tamsulosin + Tadalafil led to statistically lower intensity of urinary symptoms comparing with Tamsulosin (15.2 ±4.3 vs 21.8±3.6, p = 0.0003) or Tadalafil (15.2 ±4.3 vs 20.6 ±2.8, p = 0.0004) monotherapy. All groups of treatment demonstrated significant relief of USRs comparing with Placebo mostly beneficial in the combined therapy group. Body pain and analgesic need in Group 1 was lower than in Groups 2, 3 or 4. Side-effects were registered rarely without statistical differences in frequency between groups. Conclusions Combination therapy with Tamsulosin + Tadalafil is an effective and safe option that achieves the statistically more significant relief of USRs comparing with Tadalafil or Tamsulosin monotherapies.

show abstract

Ureteral Stents

Cited by 14 publications

References 16 publications

Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial

Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial

Sexual dysfunction in patients after double‐J catheterisation: A cross‐sectional, prospective study

Efficacy of combination therapy Tadalafil plus Tamsulosin in ureteral stents-related symptoms relief

Contact Info

Product

Resources

About